Labcorp Holdings (LH) After Investor Day And Higher Guidance Is It Fully Valued
Investor Day shifts attention to Labcorp Holdings guidance and strategy
Labcorp Holdings (LH) put its 2026 Investor Day in the spotlight as management raised full-year revenue and adjusted EPS guidance, and tied that outlook to specialty diagnostics and biopharma lab services.
Recent trading shows a mixed picture for Labcorp Holdings. The share price has climbed 13.81% over 90 days and 22.76% year to date, even though it fell 8.51% over the past month. The 1 year total shareholder return of...
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.